Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-14-028640
Filing Date
2014-05-08
Accepted
2014-05-08 16:24:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D v377916_sc13d.htm SC 13D 49721
  Complete submission text file 0001144204-14-028640.txt   50970
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Subject) CIK: 0000887151 (see all company filings)

EIN.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-42745 | Film No.: 14825286
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MILLER LLOYD I III (Filed by) CIK: 0000949119 (see all company filings)

Type: SC 13D